A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

Completed · Phase 4 · Has a placebo group

Conditions studied: Psoriasis

In brief

The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.

Key facts

Study ID

NCT05701995

Run by

Bristol-Myers Squibb

People needed

180

Starts

2023-01-31

Expected to finish

2025-05-29

Last updated by the study team

2026-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women diagnosed with stable plaque psoriasis for 6 months or more. Stable psoriasis is defined as no morphology changes or significant flares of disease activity in the opinion of the investigator.
• Deemed by the investigator to be a candidate for phototherapy or systemic therapy.
• ≥ 3% of Body Surface Area (BSA) involvement at the Screening Visit and Day 1
• Dermatology Life Quality Index (DLQI) score > 5 at the Screening Visit and Day 1
• Moderate-to-severe plaque psoriasis as defined by static Physician Global Assessment (s-PGA) ≥ 3 at the Screening Visit and Day 1

You may not qualify if…

• Target Disease Exceptions:
• Non-plaque psoriasis (that is, guttate, pustular, erythrodermic, palmoplantar only involvement or drug-induced psoriasis) at Screening Visit or Day 1
• Other protocol-defined inclusion/exclusion criteria apply.

Where it is running

• Local Institution - 0006 — Phoenix, Arizona, United States
• Local Institution - 0034 — Scottsdale, Arizona, United States
• Local Institution - 0015 — North Little Rock, Arkansas, United States
• Local Institution - 0004 — Bakersfield, California, United States
• Local Institution - 0009 — Sacramento, California, United States
• Local Institution - 0022 — San Diego, California, United States
• Local Institution - 0030 — Centennial, Colorado, United States
• Local Institution - 0024 — Washington D.C., District of Columbia, United States
• Local Institution - 0027 — Brandon, Florida, United States
• Local Institution - 0016 — Coral Gables, Florida, United States
• Riverchase Dermatology — Pembroke Pines, Florida, United States
• Local Institution - 0037 — Atlanta, Georgia, United States
• Local Institution - 0020 — Snellville, Georgia, United States
• Local Institution - 0007 — Rolling Meadows, Illinois, United States
• Local Institution - 0025 — Skokie, Illinois, United States
• Local Institution - 0036 — Springfield, Illinois, United States
• Local Institution - 0003 — Baton Rouge, Louisiana, United States
• Local Institution - 0018 — Rockville, Maryland, United States
• Local Institution - 0010 — Auburn Hills, Michigan, United States
• Local Institution - 0002 — Waterford, Michigan, United States
• Local Institution - 0017 — Las Vegas, Nevada, United States
• Local Institution - 0035 — Reno, Nevada, United States
• Local Institution - 0032 — New York, New York, United States
• Local Institution - 0013 — New York, New York, United States
• Local Institution - 0001 — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.